Design, Structure–Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990
Christopher M. McBride(Novartis (Switzerland)), Cynthia M. Shafer(Novartis (Switzerland)), Brandon Doughan, Kristin M. Brinner, Pietro Taverna, Zhenhai Gao(Jilin University), Daniel Poon(Rapt Therapeutics (United States)), Daniel L. Menezes, Kris Mendenhall, Nancy Pryer(Novartis (United States)), Timothy Machajewski(Allogene Therapeutics (United States)), Yongjin Xu, Dachuan Lei, Barry H. Levine(Novartis (Switzerland)), Alice Rico, Julie Qiaojin Lin(University of Cambridge), William Antonios-McCrea(Novartis (Switzerland)), Yi Xia, Paul A. Barsanti, Susan Fong, Teresa E. Williams(Novartis (Switzerland)), Cornelia Bellamacina, Alicia K. Louie(Novartis (Switzerland)), Tinya J. Abrams, Yasheen Zhou, Thomas F. Hendrickson, Xiaodong Lin, Abran Costales(Novartis (Switzerland)), Michael Wang, Maureen McKenna(Novartis (Switzerland)), Paul A. Renhowe(Novartis (Switzerland))
Cited by 28
Related Papers
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
|Nature|2013|735
Attitudes and perceptions of UK medical students towards artificial intelligence and radiology: a multicentre survey
|Insights into Imaging|2020|492
Food, Shelter and Safety Needs Motivating Homeless Persons' Visits to an Urban Emergency Department
|Annals of Emergency Medicine|2008|100